Advamedica
PrivateLast Round
Series B
Extension
Jul 27, 2021
Total Funding Raised
$21M
Company Overview
Advamedica is a medical technology company that develops biomaterials-based medical devices for managing trauma, surgical, and chronic wounds.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Advamedica Comparables
Compare Advamedica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beeken Biomedical | 86% | |
| CELOX Medical | 85% | |
| Core Scientific Creations | 83% | |
Advamedica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 27, 2021 | ||||
| Series B Extension | Jan 9, 2020 | ||||
| Series B | Jan 26, 2018 | ||||
| Series A | May 25, 2016 | ||||
| Grant | Sep 11, 2013 | ||||
Seed | Dec 3, 2010 |
Advamedica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GVFL | Seed |
| Omidyar Network India | Series B Extension |
| Department of Science & Technology | Grant |
| TrueScale Capital | Series B Extension |
| GVFL Limited | Seed |
| Chiratae Ventures | Series A, Series B Extension, Series B |
| RNT Associates | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2018
$7.4M round led by RNT Associates.
- May 25, 2016
$2.1M round led by Accel and Chiratae Ventures.
Advamedica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Advamedica's valuation, stock price, and market status.